RxDoctor Payments Data

Brooks Osburn, MD

Neurological Surgery · Temple Terrace, FLNPI 1932527298

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $39,389 of the $63,283 with a category attached, or 62.2%. 22 manufacturers reported payments, led by Medical Device Business Services, Inc. at 40.4% of the total. 2025 is the largest year on record at $19,624, 2.7 times the $7,156 reported in 2021.

$63,283in general payments, 2019–2025

Across 199 payments — averaging $318.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$26K
  • Carlsmed, Inc.$18K
  • Pacira Pharmaceuticals Incorporated$7K
  • Alphatec Spine, Inc$6K
  • Johnson & Johnson$2K
  • Medtronic$895
  • plus $3K from 16 others
$44,905in research payments, 2019–2025

Across 8 payments — averaging $5613.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ossdsign USA Incorporated$45K

What the payments were for

  • Consulting fees$39,38962%
  • Travel & lodging$14,75223%
  • Food & beverage$9,14214%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$63,283 in reported general payments places this provider in the 80th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$224,786
Medicare patients
307
Services billed
1,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin32$696
Celecoxib12$658
Gabapentin29$384
Cyclobenzaprine Hcl11$122
Methylprednisolone14$114
Meloxicam27$68
Tramadol Hcl14$37

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Temple Terrace

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →